Belgian Body Welcomes Clawback Exemption For Generics/Biosimilars Amid Price Cuts
Executive Summary
Belgian body Medaxes is content with the latest pharmaceutical pricing legislation in the country, which cuts generics and biosimilars prices but also exempts such drugs from pharmaceutical clawback taxes.